Thyroid Hormone Replacement Therapy
Monitoring and Dose Adjustment
- The American Association of Clinical Endocrinologists recommends monitoring TSH and free T4 after 6-8 weeks of the adjusted dose when changing thyroid medications 1
- Target TSH should be within the reference range for most patients to prevent complications of both under and over-replacement 1
- Patients with TSH <0.1 mIU/L have greater risk of complications than those with TSH between 0.1-0.45 mIU/L, including increased risk of atrial fibrillation and bone loss 2
Potential Pitfalls
- Overreplacement with levothyroxine (indicated by suppressed TSH) increases risk of atrial fibrillation and bone loss, so careful dose titration is essential 2